Skip to main content
SpringerLink
Log in

Bleeding Associated with Disseminated Intravascular Coagulation

  • Chapter
  • First Online:
Management of Bleeding Patients

  • 945 Accesses

Abstract

Disseminated intravascular coagulation (DIC) is a clinicopathological syndrome in which an underlying acute or chronic illness or injury causes systemic activation of coagulation and consumption of platelets, coagulation factors, and their regulators, leading to microvascular thrombi, organ dysfunction, and hyperfibrinolysis. Depending upon the severity and tempo of the initiating event, DIC may be asymptomatic or cause severe thrombotic or hemorrhagic complications including death. The primary driver of DIC in most conditions is tissue factor pathway activation of thrombin, although many complex cellular and activation pathways are also involved. Conditions in which bleeding is a dominant complication of DIC will be a focus of this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

aPTT:

Activated partial thromboplastin time

DIC:

Disseminated intravascular coagulation

PT:

Prothrombin time

TF:

Tissue factor

References

  1. Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131(8):845–54.

    Article  CAS  PubMed  Google Scholar 

  2. Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. Br J Haematol. 2010;148(4):507–21.

    Article  CAS  PubMed  Google Scholar 

  3. Levi M, van der Poll T. Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med. 2013;8(1):23–32.

    Article  PubMed  Google Scholar 

  4. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123(18):2768–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Levi M, van der Poll T. A short contemporary history of disseminated intravascular coagulation. Semin Thromb Hemost. 2014;40(8):874–80.

    Article  PubMed  Google Scholar 

  6. Angchaisuksiri P. Coagulopathy in malaria. Thromb Res. 2014;133(1):5–9.

    Article  CAS  PubMed  Google Scholar 

  7. Chuansumrit A, Chaiyaratana W. Hemostatic derangement in dengue hemorrhagic fever. Thromb Res. 2014;133(1):10–6.

    Article  CAS  PubMed  Google Scholar 

  8. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849–62.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg. 2011;254(1):10–9.

    Article  PubMed  Google Scholar 

  10. Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452–63.

    Article  CAS  PubMed  Google Scholar 

  11. Schwameis M, et al. Asphyxia by drowning induces massive bleeding due to hyperfibrinolytic disseminated intravascular coagulation. Crit Care Med. 2015;43(11):2394–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wada T. Coagulofibrinolytic changes in patients with post-cardiac arrest syndrome. Front Med (Lausanne). 2017;4:156.

    Article  Google Scholar 

  13. Slagboom J, et al. Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise. Br J Haematol. 2017;177(6):947–59.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Davenport RD. Pathophysiology of hemolytic transfusion reactions. Semin Hematol. 2005;42(3):165–8.

    Article  CAS  PubMed  Google Scholar 

  15. Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002;346(25):1978–88.

    Article  CAS  PubMed  Google Scholar 

  16. Kwaan HC, Cull EH. The coagulopathy in acute promyelocytic leukaemia – what have we learned in the past twenty years. Best Pract Res Clin Haematol. 2014;27(1):11–8.

    Article  PubMed  Google Scholar 

  17. Levi M. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers. Thromb Res. 2018;164(Suppl 1):S77–81.

    Article  CAS  PubMed  Google Scholar 

  18. Weitz IC. Thrombotic microangiopathy in cancer. Thromb Res. 2018;164(Suppl 1):S103–5.

    Article  CAS  PubMed  Google Scholar 

  19. Hyman DM, Soff GA, Kampel LJ. Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature. Oncology. 2011;81(2):119–25.

    Article  CAS  PubMed  Google Scholar 

  20. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112(4):851–62.

    Article  CAS  PubMed  Google Scholar 

  21. Perry JH, et al. Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin. J Card Surg. 2012;27(6):730–5.

    Article  PubMed  Google Scholar 

  22. Levi M, Meijers JC. DIC: which laboratory tests are most useful. Blood Rev. 2011;25(1):33–7.

    Article  PubMed  Google Scholar 

  23. Shahmarvand N, et al. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia. Int J Lab Hematol. 2017;39(4):375–83.

    Article  CAS  PubMed  Google Scholar 

  24. Lesesve JF, et al. Schistocytes in disseminated intravascular coagulation. Int J Lab Hematol. 2014;36(4):439–43.

    Article  PubMed  Google Scholar 

  25. Taylor FB Jr, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–30.

    Article  CAS  PubMed  Google Scholar 

  26. Bakhtiari K, et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32(12):2416–21.

    Article  PubMed  Google Scholar 

  27. Basler CF. Molecular pathogenesis of viral hemorrhagic fever. Semin Immunopathol. 2017;39(5):551–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mantha S, et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017;129(13):1763–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Kolev K, Longstaff C. Bleeding related to disturbed fibrinolysis. Br J Haematol. 2016;175(1):12–23.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Buchtele N, et al. Increased fibrinolysis as a specific marker of poor outcome after cardiac arrest. Crit Care Med. 2018;46(10):e995–e1001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16.

    Article  Google Scholar 

  32. Knight M, et al. Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol. 2010;115(5):910–7.

    Article  PubMed  Google Scholar 

  33. Lisman T, Bernal W. Hemostatic issues in pregnancy-induced liver disease. Thromb Res. 2017;151(Suppl 1):S78–81.

    Article  CAS  PubMed  Google Scholar 

  34. Nelson DB, Yost NP, Cunningham FG. Hemostatic dysfunction with acute fatty liver of pregnancy. Obstet Gynecol. 2014;124(1):40–6.

    Article  PubMed  Google Scholar 

  35. White NJ. Mechanisms of trauma-induced coagulopathy. Hematology. 2013;2013:660–3.

    Article  PubMed  Google Scholar 

  36. Shakur H, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32.

    Article  CAS  PubMed  Google Scholar 

  37. Gando S, Wada H, Thachil J. Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost. 2013;11(5):826–35.

    Article  CAS  PubMed  Google Scholar 

  38. Moore HB, et al. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator. J Trauma Acute Care Surg. 2017;83(6):1014–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Ong SY, et al. Prostate cancer-associated disseminated intravascular coagulation with excessive fibrinolysis treated with Degarelix. Case Rep Oncol Med. 2015;2015:212543.

    PubMed  PubMed Central  Google Scholar 

  40. Shirai K, Chaudhary UB. Use of low molecular weight heparin and aminocaproic acid in chronic DIC associated with prostate cancer – a case report. TheScientificWorldJournal. 2007;7:753–5.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Hayashi T, et al. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report. Ann Intern Med. 2014;161(2):158–9.

    Article  PubMed  Google Scholar 

  42. Janjetovic S, et al. Apixaban for the treatment of chronic disseminated intravascular coagulation: a report of two cases. Hamostaseologie. 2019;39(3):294–7.

    Article  PubMed  Google Scholar 

  43. Wada H, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013.

    Google Scholar 

  44. Zarychanski R, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015;43(3):511–8.

    Article  CAS  PubMed  Google Scholar 

  45. Warren BL, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286(15):1869–78.

    Article  CAS  PubMed  Google Scholar 

  46. Abraham E, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353(13):1332–41.

    Article  CAS  PubMed  Google Scholar 

  47. Abraham E, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003;290(2):238–47.

    Article  CAS  PubMed  Google Scholar 

  48. Yamakawa K, et al. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis. J Thromb Haemost. 2015;13(4):508–19.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA

    Charles Eby

Authors
  1. Charles Eby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles Eby .

Editor information

Editors and Affiliations

  1. Department of Pathology and Immunology, Division of Transfusion Medicine and Coagulation, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, USA

    Jun Teruya

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Eby, C. (2021). Bleeding Associated with Disseminated Intravascular Coagulation. In: Teruya, J. (eds) Management of Bleeding Patients. Springer, Cham. https://doi.org/10.1007/978-3-030-56338-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56338-7_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56337-0

  • Online ISBN: 978-3-030-56338-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation